Scarica l'app Stockscreener
4.70
2.81%
-0.10
Precedente Chiudi:
$4.80
Aprire:
$4.81
Volume 24 ore:
438.60K
Relative Volume:
0.10
Capitalizzazione di mercato:
$1.68B
Reddito:
$9.68M
Utile/perdita netta:
$-250.64M
Rapporto P/E:
-3.3576
EPS:
-1.3998
Flusso di cassa netto:
$-89.83M
1 W Prestazione:
+25.74%
1M Prestazione:
+5.54%
6M Prestazione:
+20.54%
1 anno Prestazione:
+202.92%
Intervallo 1D:
$4.65
$4.83
Intervallo di 1 settimana:
$3.70
$4.83
Portata 52W:
$1.38
$5.465
Precigen Inc Stock (PGEN) Company Profile
Nome
Precigen Inc
Settore
Industria
Telefono
301-556-9900
Indirizzo
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Compare PGEN vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
4.705 | 1.71B | 9.68M | -250.64M | -89.83M | -1.3998 |
VRTX
Vertex Pharmaceuticals Inc
|
447.07 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
612.18 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
871.82 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
279.68 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
156.15 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-15 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2024-03-22 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Iniziato | JP Morgan | Neutral |
| 2022-11-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-02-25 | Iniziato | Stifel | Buy |
| 2021-02-22 | Iniziato | Wells Fargo | Overweight |
| 2021-02-18 | Iniziato | B. Riley Securities | Buy |
| 2020-05-08 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Precigen Inc Borsa (PGEN) Ultime notizie
5 Best Penny Stocks That Could Skyrocket in 2026 - Insider Monkey
Precigen gains 7 year FDA orphan drug exclusivity - grafa.com
Precigen receives seven-year exclusivity for rare disease drug - Investing.com UK
Precigen receives seven-year exclusivity for rare disease drug By Investing.com - Investing.com Canada
Precigen Gains Advantage as PAPZIMEOS Granted Orphan Drug Exclusivity by FDA; Long-Term Data From Clinical Study Encouraging - ACCESS Newswire
PAPZIMEOS keeps 83% of RRP complete responders surgery-free 3+ years - Stock Titan
Precigen (PGEN) Stock Valuation Check As High P/B Multiple Meets Large DCF Upside Estimate - Yahoo Finance
Is Precigen (PGEN) a Stock to Sell After Its CFO Let Go of 41,000 Shares? - The Motley Fool
Precigen and the Recurrent Respiratory Papillomatosis Foundation Recognize International RRP Awareness Day by Elevating Patient and Community Voices - PR Newswire
Precigen jumps after Q1 beat as Papzimeos launch momentum takes hold - MSN
Precigen (NASDAQ:PGEN) Share Price Crosses Below 200-Day Moving AverageWhat's Next? - MarketBeat
PGEN: Durable RRP therapy drives rapid uptake, with global expansion and oncology pipeline advancing - TradingView
Precigen, Inc. (PGEN) is a great momentum stock: Should you buy? - MSN
PGEN News | PRECIGEN INC (NASDAQ:PGEN) - ChartMill
Precigen, Inc.'s (NASDAQ:PGEN) Path To Profitability - Moomoo
Have Precigen Insiders Been Selling Stock? - simplywall.st
H.C. Wainwright reiterates Precigen stock rating on trial data - Investing.com UK
H.C. Wainwright reiterates Precigen stock rating on trial data By Investing.com - Investing.com Australia
H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $14 - Moomoo
Precigen CCO Phil Tennant sells $131,985 in stock By Investing.com - Investing.com Australia
Precigen CFO Harry Thomasian Jr. sells $182,614 in stock - Investing.com UK
Precigen CEO Helen Sabzevari sells $519,930 in company stock - Investing.com UK
Precigen CEO Helen Sabzevari sells $519,930 in company stock By Investing.com - Investing.com South Africa
Precigen chief legal officer Lehr sells $127,011 in stock By Investing.com - Investing.com India
Precigen COO Rutul R Shah sells $186,185 in common stock By Investing.com - Investing.com India
Precigen chief legal officer Lehr sells $127,011 in stock - Investing.com
Precigen CFO Harry Thomasian Jr. sells $182,614 in stock By Investing.com - Investing.com South Africa
Precigen COO Rutul R Shah sells $186,185 in common stock - Investing.com
Precigen CCO Phil Tennant sells $131,985 in stock - Investing.com
Precigen (PGEN) CEO sells 119,250 shares in tax sell-to-cover transaction - Stock Titan
Precigen (PGEN) CFO sells 41,884 shares to cover RSU tax withholding - Stock Titan
PRECIGEN (PGEN) CCO sells 30,272 shares in tax-related transaction - Stock Titan
Precigen (PGEN) COO sells 42,703 shares to cover RSU tax withholding - Stock Titan
Precigen (PGEN) Chief Legal Officer sells shares to cover RSU tax withholding - Stock Titan
Precigen, Inc. (PGEN) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Promising Long-Term Data for Precigen (PGEN) in RRP Treatment - GuruFocus
Precigen Inc Azioni (PGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Precigen Inc Azioni (PGEN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Tennant Phil | Chief Commercial Officer |
May 28 '26 |
Sale |
4.36 |
30,272 |
131,986 |
139,369 |
| Shah Rutul R | Chief Operating Officer |
May 28 '26 |
Sale |
4.36 |
42,703 |
186,185 |
497,751 |
| Lehr Donald P. | Chief Legal Officer |
May 28 '26 |
Sale |
4.36 |
29,131 |
127,011 |
755,461 |
| Sabzevari Helen | President and CEO |
May 28 '26 |
Sale |
4.36 |
119,250 |
519,930 |
3,768,872 |
| KIRK RANDAL J | Director |
Mar 30 '26 |
Sale |
3.30 |
4,772,781 |
15,750,177 |
302,213 |
1.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):